Go back to Resource Center
Effect of the oral PKC b Inhibitor, Ruboxistaurin, on vision loss in patients with diabetic retinopathy: The PKC-DRS2 study results
2006
Journal Article
Authors:
Aiello, L.P.;
Vignati, L.;
, ;
Zhi, X.;
Davis, M.D.;
Milton, R.C.;
Group, G.A. for the
Location: Aarhus, Denmark
Go back to Resource Center